Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of Dexmedetomidine for LMA Insertion
NCT02386462Phase 4Unknown
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Anesthesia, sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Primary endpoint: Median Effective Dose (ED50) of Dexmedetomidine for LMA Insertion. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT02386462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02386462.